Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 96

Results For "National"

2150 News Found

Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students
Policy | February 22, 2024

Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students

We are achieving the target of developed India by making our young children healthy today


Dr Mandaviya addresses WHO’s public launch event of GIDH
News | February 22, 2024

Dr Mandaviya addresses WHO’s public launch event of GIDH

Global Initiative on Digital Health (GIDH) was launched by the WHO and the Government of India during the G20 Health Working Group meeting in Gandhinagar last year


Pfizer and AIF’s Project Parivartan demonstrates progress in addressing antimicrobial resistance
News | February 22, 2024

Pfizer and AIF’s Project Parivartan demonstrates progress in addressing antimicrobial resistance

Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms


Ayush Ministry to launch project of health screening and management through ayurvedic interventions
News | February 21, 2024

Ayush Ministry to launch project of health screening and management through ayurvedic interventions

The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.


European Commission approves Pfizer’s Velsipity for patients with moderately to severely active ulcerative colitis
Drug Approval | February 20, 2024

European Commission approves Pfizer’s Velsipity for patients with moderately to severely active ulcerative colitis

VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU


Briefs: IOL Chemicals and Pharmaceuticals and Auro Peptides
News | February 20, 2024

Briefs: IOL Chemicals and Pharmaceuticals and Auro Peptides

IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China


Lupin receives approval from USFDA for Minzoya
Drug Approval | February 17, 2024

Lupin receives approval from USFDA for Minzoya

Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy


Internal restructuring of foreign subsidiaries at Bliss GVS Pharma
News | February 17, 2024

Internal restructuring of foreign subsidiaries at Bliss GVS Pharma

The restructuring aims to create synergies across the business and strengthen capital structure


YS Biopharma appoints new Directors
People | February 17, 2024

YS Biopharma appoints new Directors

The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024


Ascentage Pharma’s Phase III study of Olverembatinib cleared by FDA
Drug Approval | February 14, 2024

Ascentage Pharma’s Phase III study of Olverembatinib cleared by FDA

The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.